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A B S T R A C T   
Hypocrealean entomopathogenic fungi (EPF) (Sordariomycetes, Ascomycota) are natural regulators of insect 
populations in terrestrial environments. Their obligately-killing life-cycle means that there is likely to be strong 
selection pressure for traits that allow them to evade the effects of the host immune system. In this study, we 
quantified the effects of cordycepin (30-deoxyadenosine), a secondary metabolite produced by Cordyceps militaris 
(Hypocreales, Cordycipitaceae), on insect susceptibility to EPF infection and on insect immune gene expression. 
Application of the immune stimulant curdlan (20 µg ml  1, linear beta-1,3-glucan, a constituent of fungal cell 
walls) to Drosophila melanogaster S2r cells resulted in a significant increase in the expression of the immune 
effector gene metchnikowin compared to a DMSO-only control, but there was no significant increase when curdlan 
was co-applied with 25 µg ml  1 cordycepin dissolved in DMSO. Injection of cordycepin into larvae of Galleria 
mellonella (Lepidoptera: Pyralidae) resulted in dose-dependent mortality (LC50 of cordycepin  2.1 mg per insect 
6 days after treatment). Incubating conidia of C. militaris and Beauveria bassiana (Hypocreales, Cordycipitaceae; 
an EPF that does not synthesize cordycepin) with 3.0 mg ml  1 cordycepin had no effect on the numbers of 
conidia germinating in vitro. Co-injection of G. mellonella with a low concentration of cordycepin (3.0 mg ml  1) 
plus 10 or 100 conidia per insect of C. militaris or B. bassiana caused a significant decrease in insect median 
survival time compared to injection with the EPF on their own. Analysis of predicted vs. observed mortalities 
indicated a synergistic interaction between cordycepin and the EPF. The injection of C. militaris and B. bassiana 
into G. mellonella resulted in increased expression of the insect immune effector genes lysozyme, IMPI and gal-
lerimycin at 72 h post injection, but this did not occur when the EPF were co-injected with 3.0 mg ml  1 cor-
dycepin. In addition, we observed increased expression of IMPI and lysozyme at 48 h after injection with 
C. militaris, B. bassiana and sham injection (indicating a wounding response), but this was also prevented by 
application of cordycepin. These results suggest that cordycepin has potential to act as a suppressor of the im-
mune response during fungal infection of insect hosts.   
1. Introduction 
In order to successfully grow and reproduce in its host, a pathogen 
must evade the effects of the host immune system. This can be done 
through passive mechanisms (e.g. avoiding immune detection) or by 
actively interfering with host immune responses (Schmid-Hempel, 
2009). Understanding the strategies used by pathogens for immune 
evasion provides valuable insights into the evolution of virulence in 
host-parasite relationships (Schmid-Hempel, 2009) but our present un-
derstanding of immune evasion in insect pathogens is not well 
developed. 
Hypocrealean entomopathogenic fungi (EPF) (Sordariomycetes, 
Ascomycota) are obligately-killing parasites that infect a wide range of 
insects and are common in terrestrial ecosystems (Vega et al., 2009). 
Infection occurs by percutaneous growth of fungal spores into the hae-
mocoel, from where the fungus starts to proliferate and consume host 
tissues, resulting in insect death (Chandler, 2016). In laboratory assays 
insect death usually occurs 3–7 days after infection, however this can 
take longer in a natural situation and varies between EPF species 
(Chandler, 2016). If environmental conditions are favourable, the 
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fungus grows back out of the insect cadaver to produce ascospores from 
fruiting bodies (for sexually reproducing forms) or vegetative conidia 
(for asexual reproduction), which are released into the environment to 
be acquired by naïve hosts. This particular life cycle, with transmission 
being dependent upon the pathogen killing its host, imposes a strong 
selection pressure for traits that confer high virulence in order to 
maximise pathogen fitness (Roy et al., 2006; Boomsma et al., 2014). 
Hypocrealean EPF produce a range of secondary metabolites during 
infectious growth (de Bekker et al., 2013), and there is experimental 
evidence that some of these disrupt cellular and systemic immune de-
fences, such as the destruxins, a group of cyclic hexadepsipeptides 
produced by Metarhizium species (Vilcinskas et al., 1997a, 1997b; Pal 
et al., 2007; Zimmermann, 2007a, 2007b). Indirect evidence on the anti- 
immune function of some other EPF metabolites comes from their use as 
immune suppressors in human medicine. Examples include cyclo-
sporine, which is used to treat autoimmune diseases and to prevent 
rejection in organ transplantation, and which is a natural product from 
Tolypocladium inflatum (Hypocreales, Ophiocordycipitaceae) (Survase 
et al., 2011), as well as the immune-modulating drug fingolimod, used in 
the treatment of multiple sclerosis, and which is a synthetic derivative of 
myriocin, produced by Cordyceps/Isaria cicadae s.l. (previously known as 
Isaria sinclairii, currently undergoing taxonomic revision; Hypocreales, 
Clavicipitaceae) (Fujita et al., 1994; Strader et al., 2011; Kepler et al., 
2017). The homologies between the innate immune systems of mam-
mals and insects (Stokes et al., 2015) probably explains why immuno-
suppressing metabolites from EPF are also able to affect the human 
immune system. The innate immune systems are sufficiently similar that 
insects are also being used increasingly as in vivo models of pathogen 
virulence in medical research (Sheehan et al., 2018). 
Here, we present the results of a study on insect immune interference 
by cordycepin (30-deoxyadensoine), a secondary metabolite produced 
by the teleomorphic hypocrealean EPF Cordyceps militaris (Hypocreales, 
Cordycipitaceae) (Cunningham et al., 1950; Shih et al., 2007; Tuli et al., 
2014). This fungus occurs naturally in temperate and sub-tropical areas 
within Asia, Europe, and North and South America, although it is 
considered to be rare (Shrestha et al., 2012). It is a host specialist, 
causing natural infections predominantly in lepidopteran larvae and 
pupae (Shrestha et al., 2012). Cordycepin has been investigated previ-
ously for its pharmacological potential, particularly in connection with 
the use of C. militaris fruiting bodies as a traditional herbal medicine 
(Paterson, 2008). It has been reported to have anti-inflammatory (Kim 
et al., 2006; Jeong et al., 2010; Kondrashov et al., 2012; Zhang et al., 
2014; Yang et al., 2015; Ashraf et al., 2019) as well as anti-tumour 
(Nakamura et al., 2006) and anti-angiogenic properties (Lu et al., 
2014) in studies with mammalian cells, but little is known about its 
effect on insects. For the present study, we addressed the topic using 
Drosophila melanogaster (Diptera: Drosophilidae) cell culture and 
Galleria mellonella (Lepidoptera: Pyralidae) live caterpillars as experi-
mental systems (Lemaitre et al., 1995; Mylonakis et al., 2005; Bergin 
et al., 2006; O’Neill, 2006; Ramarao et al., 2012; Harding et al., 2013). 
Firstly, we quantified the effect of cordycepin on the expression of 
immunity-related genes in a D. melanogaster S2r cell line treated with 
activators of the immune response. Secondly, we measured the survival 
of G. mellonella larvae, together with the expression of immunity-related 
genes, following injection with cordycepin on its own and in combina-
tion with C. militaris and Beauveria bassiana (Hypocreales, Cordycipita-
ceae), a related, asexually-reproducing EPF species that does not 
synthesize cordycepin (Xia et al., 2017). The aim was to provide new 
information on the effect of cordycepin on insect immune gene expres-
sion under the controlled conditions achievable using a cell-based assay, 
as well as the more biologically-complex conditions of a whole-animal 
environment. 
2. Materials and methods 
2.1. Experimental material 
D. melanogaster S2r cells (Schneider, 1972; Ramet et al., 2001) were 
cultured in 15 ml cell culture flasks (VWR, Radnor, USA) with 12 ml of 
Schneider Drosophila Insect Medium (Thermo Fisher Scientific, Wal-
tham, USA) supplemented with 10% foetal bovine serum (FBS; Sigma- 
Aldrich) and 10% penicillin-streptomycin (Sigma-Aldrich, St Louis, 
USA). Cell density was determined by trypan blue staining (Strober, 
2001). Cells were subcultured when their density reached 1  107 cells 
ml  1. All cells used in experiments were between passages 5–15. 
Final instar, non-diapausing G. mellonella larvae were purchased 
from Wazp Brand UK Ltd. (Yorkshire, UK). They were maintained at 
15 C in darkness and larvae between 200 and 300 mg were selected for 
experiments. Cordycepin (Sigma-Aldrich, St Louis, USA) was prepared 
as a stock solution (100 mg ml  1 in DMSO; Thermo Fisher Scientific, 
Waltham, USA) and diluted with sterile 0.01% Triton X-100 (Merck, 
Darmstadt, Germany) wetting agent in DEPC-treated water plus 0.1 mg 
ml  1 pentostatin (20-deoxycoformycin; Sigma-Aldrich, St Louis, USA) 
(Johnston, 2011). 
Laboratory bioassays with entomopathogenic fungi were done using 
B. bassiana strain 433.99 and C. militaris strain ARSEF 11703 (Supple-
mentary Table 1). Stock cultures of the strains were stored in cryo-
preservation (Chandler, 1994). Laboratory cultures were grown from 
stock cultures on Sabouraud Dextrose Agar (SDA; Thermo Fisher Sci-
entific, Waltham, USA) slopes and maintained at 5 C for up to six 
months. Subcultures for laboratory experiments were grown on SDA 
from slope cultures and incubated in darkness at 23 C for 10–14 days. 
Conidia were harvested in sterile 0.01% Triton X-100 and suspensions 
filtered through milk filters (Lantor Ltd, Bolton, UK) to remove hyphal 
fragments. Conidia were counted using an Improved Neubauer haemo-
cytometer and aliquots prepared at different concentrations as required. 
2.2. Effect of cordycepin treatment on the response of D. melanogaster 
S2r cells to simulated immune challenge 
D. melanogaster S2r cells were cultured as described above. Cells 
were collected by centrifugation at 1500  g for 5 min at 4 C, the su-
pernatant removed and cells resuspended in Schneider Drosophila Insect 
Medium with 10% FBS. Aliquots (3 ml) were pipetted into each well of a 
6-well plate (TPP tissue culture plate, Sigma-Aldrich, St Louis, USA) at a 
density of approximately 8  105 cells ml  1. To determine the effect of 
cordycepin on gene expression, cells were treated with the immune 
response stimulants curdlan (linear beta-1,3-glucan; 20 µg ml  1; Car-
bosynth Ltd., Compton, UK) or crude LPS (lipopolysaccharide; 20 µg 
ml  1; Sigma-Aldrich, St Louis, USA), followed by addition of 25 µg ml  1 
(100 μM) cordycepin solution in DMSO, or DMSO only. An untreated 
control was also included. Curdlan is structurally similar to fungal cell 
wall polysaccharides and is used to stimulate an anti-fungal immune 
response (Kumar et al., 2009), whereas crude LPS (which also contains 
peptidoglycan) is found in the outer membrane of gram-negative bac-
teria and is used to stimulate an anti-(gram-negative) bacterial immune 
response (Tanji and Ip, 2005). Cells were incubated for 4 h at 25 C, then 
RNA was extracted ahead of RT-qPCR (see below). 
2.3. Effect of cordycepin treatment on the survival of G. mellonella larvae 
infected with the EPF C. militaris and B. bassiana 
2.3.1. Dose-response bioassays 
Dose response bioassays were done with cordycepin and EPF alone 
against G. mellonella larvae. For the cordycepin dose-response bioassay, 
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10 final instar G. mellonella larvae were cooled on ice for 5 min, then 
injected in the right front proleg with 30 μl cordycepin at 1.0, 1.8, 3.3, 
6.0 or 11 mg ml  1 (equivalent to 30, 55, 100, 180, and 330 μg per insect 
respectively, with a sham injection control) using a 0.3 ml microfine 
insulin syringe (BD, Franklin Lakes, USA). Where the suspension bled 
from larvae following injection, the larvae were discarded and not 
included in the experiment. Immediately after treatment, insects were 
placed individually in Petri dishes on damp filter paper, sealed with 
Parafilm, and maintained in darkness at 20 C. Survival of the larvae was 
monitored every 24 h for seven days. The bioassay was repeated on three 
separate occasions, resulting in a total of 30 larvae in each treatment. 
The DRC package in R (Ritz et al., 2015) was used to estimate lethal 
concentration (LC) and lethal dose (LD) values at day 6. The EPF dose 
response bioassay was done in the same way, with final instar 
G. mellonella larvae being injected with 30 μl of conidia suspensions of 
C. militaris and B. bassiana at concentrations of 1  103, 1  104, 1  105, 
1  106 and 1  107 conidia ml  1 (equivalent to 30, 300, 3  103, 3 
104, 3  105 conidia per insect respectively) in sterile 0.01% Triton X- 
100 (10 insects per treatment, sham injection controls, three indepen-
dent repeats, LC and LD estimations at day 6). 
2.3.2. EPF spore germination 
The effect of cordycepin on EPF spore germination was measured as 
follows: for both B. bassiana and C. militaris, 100 μl conidia suspension 
(1  107 conidia ml  1 in sterile 0.01% Triton X-100) was combined with 
30 μl of cordycepin (100 mg ml  1) and made up to a final volume of 1 ml 
using Sabouraud Dextrose Broth (Sigma-Aldrich, St Louis, USA). This 
gave final concentrations of 1  106 conidia ml  1 and 3.0 mg ml  1 (12 
mM) cordycepin (equivalent to the LC15 in the G. mellonella dose 
response bioassay). The mixture was incubated in darkness at 23 C for 
24 h, after which the germination of approximately 100 conidia was 
recorded by examination under a microscope. A conidium was consid-
ered germinated if the germ tube was longer than the length of the 
conidium. The experiment was performed on three occasions. Percent-
age conidia germination was analysed using a one-way ANOVA 
following a logit transformation (Warton and Hui, 2011) and statistical 
normality testing (Shapiro and Wilk, 1965) in SPSS (IBM Corp., 2016). 
2.3.3. Effect of cordycepin application on G. mellonella susceptibility to 
EPF 
A bioassay was done to measure insect survival following EPF 
infection supplemented with cordycepin. Batches of 20 final instar 
G. mellonella larvae were injected, as described above, with 30 μl conidia 
suspension of B. bassiana or C. militaris at concentrations of 3.3  102 
and 3.3  103 conidia ml  1 (equivalent to 10 and 100 conidia per insect 
respectively) in 0.01% Triton X-100 with/without 3.0 mg ml  1 cordy-
cepin. Where the suspension bled from larvae following injection, the 
larvae were discarded and not included in the experiment. Assessment of 
larval survival was done as described above for 11 days and the exper-
iment was repeated on three separate occasions, resulting in a total of 30 
larvae for each treatment. For each insect batch, 10 individuals were 
used for survival analysis, while 5 individuals were removed at 0 h (t0), 
48 h and 72 h, and snap frozen in liquid nitrogen for RNA extraction and 
quantification of gene expression (Section 2.4). Changes in insect sur-
vival were visualised using a Kaplan-Meier estimator, and analysed 
using a Cox proportional-hazards regression model with replicate and 
treatment as factors, in which the median survival time (MST) of the 
insect populations of each treatment and their 95% confidence intervals 
were calculated, and pairwise comparisons were done using a log-rank 
χ2 test (Cox, 1972; IBM SPSS Statistics Version 24; Bewick et al., 
2004). The outcome of combining cordycepin with B. bassiana or 
C. militaris on total percentage mortality (synergism, antagonism, or 
additive effect) at day 6 and day 11 was investigated using the fractional 
product method for combination treatments, where the effect of the 
combination is given as (1   X), where X   (1   A)(1   B) and where A 
 the proportional effect of agent A on its own, and B is the proportional 
effect of agent B (Webb, 1963). 
2.4. Quantification of expression of insect immune-associated genes 
RNA was extracted from D. melanogaster S2r cells using the 
ReliaPrep RNA Cell Miniprep system (Promega, Madison, USA) 
following manufacturer’s instructions. For RNA extraction from 
G. mellonella, individual snap frozen larvae were ground in liquid ni-
trogen using an autoclaved mortar and pestle. RNA was extracted from 
50 mg of material using the phenol: chloroform method with Tri-reagent 
(Sigma-Aldrich, St Louis, USA) then treated with DNase I (Sigma- 
Aldrich, St Louis, USA) following manufacturer’s instructions. After 
washing with 75% ethanol, air dried RNA pellets were resuspended in 
50 μl DEPC-treated water and stored at   80 C. RNA concentrations 
were measured using a NanoDrop ® ND-100 spectrophotometer 
(Thermo Fisher Scientific, Waltham, USA). cDNA was synthesized using 
Superscript kits (Thermo Fisher Scientific, Waltham, USA): Superscript 
III was used to reverse transcribe D. melanogaster RNA (100 μg) and 
Superscript II was used for G. mellonella RNA (500 μg), both with 
random hexamers. Manufacturer’s instructions were followed, with the 
exception that 0.5 μl (100 units) SuperScript III was used for reactions. 
The expression of insect immune associated genes was quantified by RT- 
qPCR using a Lightcycler 480 (Roche Holding AG, Basel, Switzerland). 
For D. melanogaster S2r cells, expression levels were quantified for 
genes encoding the ribosomal protein RP49 (used as the reference), and 
the antimicrobial peptides (AMPs) metchnikowin and attacin A. For 
G. mellonella, expression levels were quantified for genes encoding the 
following proteins: the ribosomal protein S7e (reference); the AMPs 
gallerimycin and galiomicin; lysozyme; and the insect metalloproteinase 
inhibitor (IMPI). Gene expression in G. mellonella was measured for 
larvae injected with EPF /  exogenous cordycepin, as well as for sham 
injections and uninjected controls. Primers for all genes are shown in 
Table 1. SensiFAST SYBR No-ROX (Bioline, London, UK) was used for 
RT-qPCR, each reaction contained: 5 μl SYBR Green, 2 μl DEPC treated 
water, 1 μl forward primer (10 μM), 1 μl reverse primer (10 μM) and 1 μl 
cDNA. The conditions were: 95 C 2 min, 40 (95 C 5 s, 60 C 10 s and 
72 C 20 s). The comparative CT method (also known as the 2  ΔΔCT 
method) (Schmittgen and Livak, 2008) was used to calculate fold 
changes in gene expression compared to untreated samples with 
correction for the internal control. Each gene of interest was analysed 
independently. For D. melanogaster, data on relative gene expression 
were tested for normality (Shapiro and Wilk, 1965) before being subject 
to ANOVA, while for G. mellonella, the data were tested for normality 
and then analysed using Kruskal-Wallis H tests (IBM SPSS Statistics 
Version 24). Where overall significant differences were observed, post- 
Table 1 
Primers used to monitor immune-related gene expression in G. mellonella and 
D. melanogaster.  
Gene Primer sequence (50-30) Reference 
gallerimycin TATCATTGGCCTTCTTGGCTG Wojda and Jakubowicz 
(2007) GCACTCGTAAAATACACATCCGG 
galiomicin TCGTATCGTCACCGCAAAATG Wojda et al. (2009) 
GCCGCAATGACCACCTTTATA 
lysozyme TCCCAACTCTTGACCGACGA Altincicek and Vilcinskas 
(2006) AGTGGTTGCGCCATCCATAC 
IMPI AGATGGCTATGCAAGGGATG Altincicek and Vilcinskas 
(2006) AGGACCTGTGCAGCATTTCT 
S7e ATGTGCCAATGCCCAAGTTG Wojda and Jakubowicz 
(2007) GTGGCTAGGCTTGGGAAGAAT 
attacin A AGGTTCCTTAACCTCCAATC Jin et al. (2008) 
CATGACCAGCATTGTTGTAG 
metchnikowin TCTTGGAGCGATTTTTCTGG Castillo et al. (2013) 
AATAAATTGGACCCGGTCTTG 
RP49 GACGCTTCAAGGGACAGTATCTG Gobert et al. (2003) 
AAACGCGGTTCTGCATGAG  
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hoc analysis was performed using a Tukey HSD post hoc test (following 
ANOVA) or the Dunn-Bonferroni post hoc method (following Kruskal- 
Wallis tests). 
3. Results 
3.1. Effect of cordycepin treatment on gene expression in D. melanogaster 
S2r cells following immune challenge 
The relative expression of the immune effector genes metchnikowin 
and attacin was quantified in a D. melanogaster S2r cell line treated 
separately with two activators of the immune response, curdlan and LPS, 
with and without the addition of 25 µg ml  1 cordycepin (Fig. 1). There 
was significant variation among treatments in the relative expression for 
both metchnikowin (F5,17  5.93, P < 0.01) and attacin A (F5,17  3.48, P 
< 0.05). Application of curdlan significantly elevated the mean relative 
expression of metchnikowin compared to the DMSO-only control or 
DMSO plus cordycepin (Tukey HSD, P < 0.05, approximately 6-fold 
increase). When cordycepin was co-applied with curdlan, there was no 
significant difference in mean relative gene expression compared to 
DMSO-only or DMSO plus cordycepin (P > 0.05, approximately 2.5-fold 
change), nor was there a significant difference between the mean rela-
tive expression of metchnikowin for the curdlan-only treatment vs. cur-
dlan  cordycepin (P > 0.05, 2.5-fold change). Treatment with LPS, or 
LPS  cordycepin, did not have a significant effect on relative expression 
of metchnikowin compared to the DMSO-only control (P > 0.05, 2-fold 
increase for LPS only, no fold change for LPS  cordycepin) (Fig. 1A). 
For attacin A, post hoc comparisons showed that relative expression was 
significantly higher following treatment with curdlan compared to the 
DMSO plus cordycepin- treatment (P < 0.05, approximately 7-fold in-
crease) (Fig. 1B). 
3.2. Effect of cordycepin treatment on the survival of G. mellonella larvae 
infected with C. militaris and B. bassiana 
In this set of experiments we investigated whether application of 
exogenous cordycepin would affect the susceptibility of G. mellonella 
larvae to fungal infection and impact on the expression of host immune 
genes. We used a low dose of cordycepin that did not inhibit fungal 
activity and did not cause excessive insect mortality on its own. 
3.2.1. Dose-response bioassays of B. bassiana and C. militaris against 
G. mellonella larvae 
Larvae of G. mellonella were treated with either EPF or cordycepin to 
established the impact of these treatments individually on insect sur-
vival. There was a positive relationship between G. mellonella mortality 
and dose of cordycepin applied (Fig. 2, Weibull type 1 model), the LC15, 
LC50, LD15 and LD50 were also calculated on day 6 after treatment and 
found to be 2.91 (0.35) mg ml  1, 6.96 (1.03) mg ml  1, 87.95 
(10.79) µg per larvae and 209.34 (30.70) µg per larvae, respectively. 
Individual larvae receiving a lethal dose of cordycepin became distinctly 
grey in colour between 24 and 48 h prior to death (Supplementary 
Fig. 1) and their movement declined markedly. After death, cadavers 
turned black and their abdomens were fluid-filled. G. mellonella larvae 
were susceptible to lethal infections by both B. bassiana and C. militaris 
(Fig. 3; estimated B. bassiana LC50 (day 6)  3.6  10
3 (9.4  102) 
conidia ml  1, LD50  1.1  10
2 (2.8  101) conidia per insect; 
C. militaris LC50  4.0  10
4 (9.1  103) conidia ml  1, LD50  1.2  10
3 
(2.8  102) conidia per insect; two-parameter log-logistic model). 
3.2.2. EPF conidia germination 
Conidia of C. militaris and B. bassiana were incubated with cordy-
cepin to identify any inhibitory effects on germination. There was no 
significant effect of cordycepin treatment (3 mg ml  1) on the numbers of 
B. bassiana and C. militaris conidia germinating in vitro after 24 h (F3,11 
1.045, P > 0.05). The mean germination (back-transformed) of 
B. bassiana conidia populations was 75% and 79% at 0 and 3 mg ml  1 of 
cordycepin respectively, while for C. militaris conidia it was 82% and 
79% respectively (Fig. 4). 
3.2.3. Effect of cordycepin application on G. mellonella susceptibility to 
fungal infection 
A laboratory bioassay was done to quantify the effects on 
G. mellonella survival of co-applying 3 mg ml  1 cordycepin with 
C. militaris or B. bassiana at doses of 10 and 100 conidia per insect. 
Mortality of G. mellonella larvae in the sham injection control was 3.3% 
at 11 days post injection (dpi) (Supplementary Table 2). Injection of 
larvae with 3 mg ml  1 cordycepin resulted in a mortality of 13.3%, 
which was in keeping with the results from the earlier cordycepin dose 
response bioassay (Fig. 2) but was not statistically significantly different 
from the sham injection control (Supplementary Table 2). Compared to 
injection of EPF on their own, co-injection of 3 mg ml  1 cordycepin with 
Fig. 1. Expression of AMPs in D. melanogaster S2r cells in response to cordycepin treatment. S2r cells (three biological replicates) were treated with DMSO (dark 
grey bars) or DMSO plus 25 µg ml  1 (100 µM) cordycepin (light grey bars). Immune challenge was simulated using 20 µg ml  1 LPS or curdlan. Cells were sampled 4 h 
after treatment. Fold changes in gene expression were calculated using the 2  ΔΔCT method (Schmittgen and Livak, 2008) compared to untreated samples with 
correction for the internal control (RP49). Relative expression of A) metchnikowin and B) attacin A is shown. Error bars show  SEM and different lowercase letters 
indicate significant differences (p < 0.05; ANOVA, Tukey HSD post hoc tests). 
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B. bassiana or C. militaris caused a significant decrease in median sur-
vival time of c. 24 h in all cases (Supplementary Table 2, log rank chi 
squared > 3.841, P < 0.05; also see survival curves, Fig. 5) and this was 
reflected by an increase in the hazards ratio (Supplementary Table 2). A 
dose of 10 conidia per insect of C. militaris resulted in 36.7% mortality at 
11 dpi, meaning that median survival time could not be estimated 
(Supplementary Table 2). At day 6 the predicted mean mortality of 
B. bassiana  cordycepin combination, calculated from the fractional 
product of B. bassiana and cordycepin mortality individually, was 0% at 
a dose of 10 conidia per insect (observed value  26.7%) and 46.7% at a 
dose of 100 conidia per insect (observed value  80%). At day 11 the 
predicted mean mortality of the C. militaris  cordycepin combination 
was 45.1% at a dose of 10 conidia per insect (observed value  80%), 
and 65.3% at a dose of 100 conidia per insect (observed value  80%). 
Both the results on days 6 and 11 after treatment indicate that there was 
a synergistic effect of the combination treatment with EPF and cordy-
cepin (Webb, 1963). 
3.3. Effect of cordycepin treatment on the expression of immune-related 
genes in G. mellonella larvae infected with B. bassiana and C. militaris 
In order to provide information on the possible mechanism by which 
cordycepin affects fungal infection, the expression of four G. mellonella 
immune-related genes (galiomicin, gallerimycin, IMPI and lysozyme) was 
quantified at 48 h and 72 h in larvae injected with B. bassiana or 
Fig. 2. Proportion mortality of G. mellonella larvae following cordycepin treatment. Mean proportional mortality of G. mellonella larvae (N  30 for each dose) 
injected with 1, 1.82, 3, 6 and 11 mg ml  1 of cordycepin and a DMSO control on day 6 after treatment. A type 1 Weibull model is fitted to the response. 
Fig. 3. Proportion mortality of G. mellonella larvae following treatment with EPF. Mean proportional mortality of G. mellonella larvae (N  30 for each dose) injected 
with B. bassiana and C. militaris conidia at six concentrations on day 6 after treatment. A two-parameter log-logistic model is fitted to the responses. 
Fig. 4. The impact of cordycepin on EPF germination. Mean (back-trans-
formed) percentage germination of B. bassiana 433.99, C. militaris 11703, and 
M. brunneum 275.86 conidia  SE following incubation for 24 h with 0 (dark 
grey) and 3 (light grey) mg ml  1 of cordycepin. 
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Fig. 5. Survival curves of G. mellonella treated with cordycepin and EPF. Survival of G. mellonella larvae injected with 10 or 100 B. bassiana conidia or C. militaris 
conidia. Solid lines show observed mortalities, those lines ending in ‘’ indicate censored populations. Dashed lines indicate the expected population decline (shaded 
area illustrates the standard error) estimated by fitting a binomial generalized logistic model. Pale grey lines indicate treatment with cordycepin (3 mg ml  1) and 
dark grey with a DMSO control. N  30 per treatment. P values are the result of a log-rank test. 
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C. militaris /  cordycepin (Fig. 6). The experiment also included a 
sham injection control and an untreated (un-injected) control. Pair-
wise comparisons (Dunn-Bonferroni method) showed that, at 48 h, in-
jection with C. militaris, B. bassiana, and sham injection resulted in a 
significantly larger increase (P < 0.05) in relative expression of IMPI and 
lysozyme compared to the untreated control. At 72 h, injection with 
C. militaris and B. bassiana resulted in a significantly larger increase (P <
0.05) in relative expression of gallerimycin, IMPI, and lysozyme compared 
to the untreated control, but there was no significant difference between 
sham injection and the untreated control for any of the four genes (P >
Fig. 6. Expression of immune-related genes in response to cordycepin and C. militaris or B. bassiana 48 h and 72 h after treatment. The expression of galiomicin, 
gallerimycin, IMPI and lysozyme in response to stimulation by C. militaris or B. bassiana injection and sham (Triton X-100) injection 48 h and 72 h. Fold changes in 
gene expression were calculated using the 2  ΔΔCT method (Schmittgen and Livak, 2008) compared to untreated samples with correction for the internal control (S7e). 
Treatment without cordycepin is shown by dark grey bars and with cordycepin (3 mg ml  1) by light grey bars, expression in uninjected insects is also included. N 
13–15 per treatment. Different letters above bars indicate statistically significant differences (p < 0.05) identified using the Dunn-Bonferroni post hoc method 
following a Kruskal-Wallis test. 
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0.05). In contrast, there was no significant increase (P > 0.05) in relative 
immune gene expression when cordycepin was co-applied with 
C. militaris, B. bassiana or on its own. Addition of cordycepin caused 
between 2-fold to 7-fold reduction in relative gene expression depending 
on the EPF species and immune gene (Fig. 6). Compared to injection 
with B. bassiana only, co-injection of B. bassiana  cordycepin resulted 
in a reduction in expression of: (i) galiomicin by ~3.5 (P < 0.01) at 48 h 
and ~3 (P < 0.01) at 72 h; (ii) gallerimycin by ~3 at both 48 h (P <
0.05) and 72 h (P < 0.05); (iii) IMPI by ~7.5 (P < 0.001) at 48 h and 
~5 (P < 0.001) at 72 h; and (iv) lysozyme by ~6.5 (P < 0.001) at 48 h 
and ~3.5 (P < 0001) at 72 h. A similar pattern of reduced gene 
expression was observed with C. militaris and cordycepin. Compared to 
injection with C. militaris only, co-injection of C. militaris  cordycepin 
resulted in a reduction in expression of: (i) galiomicin by ~5 (P <
0.001) at 48 h and ~4.5 (P < 0.001) at 72 h; (ii) gallerimycin by ~2 at 
both 48 h (P < 0.01) and 72 h (P < 0.05); (iii) IMPI by ~x4 (P < 0.005) at 
48 h and ~6 (P < 0.001) at 72 h; and (iv) lysozyme by ~6.5 (P <
0.01) at 48 h and ~4 (P < 0.005) at 72 h. Compared to the sham in-
jection control, injection of cordycepin resulted in a reduction in 
expression of: (i) galiomicin by ~3 (P < 0.01) at 72 h; (ii) gallerimycin 
by ~2 (P < 0.02) at 48 h; (iii) IMPI by ~3 (P < 0.001) at 48 h and 
~3 (P < 0.001) at 72 h; and (iv) lysozyme by ~2.5 (P < 0.001) at 48 
h. 
4. Discussion 
In order to complete their parasitic life cycle, obligately-killing EPF 
such as C. militaris must nullify the effects of host immune defences (Vey 
et al., 2002; Wang and St Leger, 2006; Pal et al., 2007; Butt et al., 2016). 
The inference from our findings is that the C. militaris secondary 
metabolite cordycepin is capable of acting as an insect immune modu-
lator, dampening down the upregulation of defence genes in response to 
fungal infection. This suppression of the immune response may facilitate 
infection of insects by C. militaris. To our knowledge, this is the first 
report of the effects of cordycepin on immune gene expression in insects. 
The statistical variation that we observed in the D. melanogaster S2r
cell assay means that some caution is needed in interpretation of the 
results, but overall, they suggest that cordycepin may have an inhibitory 
effect on expression of the anti-fungal AMP gene metchnikowin, despite 
the downregulation in expression of this gene not being significant 
following curdlan treatment. Specifically, while immune challenge with 
the anti-fungal elicitor curdlan resulted in increased expression of 
metchnikowin compared to the DMSO-only control, this did not occur 
when curdlan was applied in the presence of cordycepin, suggesting that 
cordycepin was able to inhibit upregulation of this immune gene (post 
hoc comparisons showed no significant difference between treatment 
with curdlan vs. curdlan  cordycepin, but we expect that higher doses 
of cordycepin are likely to have resulted in a greater effect on gene 
expression). Metchnikowin (Levashina et al., 1995), which is specific to 
members of the Drosophilidae, is synthesized via the Toll and Imd 
pathways in response to fungal or bacterial infection (De Gregorio et al., 
2002; Imler and Bulet, 2005). As expected, treatment with the anti- 
(gram negative) bacterial elicitor LPS (Tanji and Ip, 2005) did not result 
in increased metchnikowin expression compared to the control. However, 
unexpectedly, we observed no significant increase in expression of the 
AMP gene attacin A in response to LPS in our study. Attacins are 
conserved across different species in the Lepidoptera and Diptera, they 
are broadly considered to be active against gram-negative bacteria 
(Lemaitre and Hoffmann, 2007; Yi et al., 2014), although in 
D. melanogaster there are multiple attacin genes (A, B1, D) which are 
expressed in response to gram-negative bacteria and fungi. The 
expression of attacin D is controlled by the IMD pathway, which is 
activated by gram-negative bacteria (De Gregorio et al., 2002). The 
expression of attacins A and B1 is controlled by both the Toll and IMD 
pathways and responds to infections by fungi and bacteria (De Gregorio 
et al., 2002). Previous experiments with Aedes aegypti (Diptera: 
Culicidae) and D. melanogaster have found that attacin is expressed in 
response to B. bassiana infection (Lemaitre et al., 1997; De Gregorio 
et al., 2002; Dong et al., 2012; Yi et al., 2014). Our finding of signifi-
cantly increased attacin A expression in the D. melanogaster S2r cell 
assay in the curdlan vs. cordycepin-only treatment, provides some 
tentative support that attacin A expression is responsive to fungal 
infection. 
The inhibitory effects of cordycepin on the anti-fungal insect im-
mune immune response was further supported by the results from our 
G. mellonella experiment, where application of cordycepin prevented 
increased expression of different immune effector genes in response to 
fungal infection, and resulted in faster host insect death. Injection of 
G. mellonella larvae with B. bassiana, C. militaris, or a sham injection, 
resulted in increased expression of lysozyme and IMPI at 48 h after 
treatment. Meanwhile, at 72 h we observed elevated expression of 
lysozyme, IMPI, and gallerimycin (but not galiomycin) in response to 
B. bassiana and C. militaris injection, but there was no elevated immune 
gene expression in response to sham injection compared to the untreated 
control, suggesting that the gene expression response to wounding was 
short lived. Applying exogenous cordycepin alongside B. bassiana or 
C. militaris, or as an addition to the sham injection, dampened down the 
expression of these immune genes so that relative expression was no 
different from the untreated control. Gallerimycin and galiomycin are 
both anti-fungal defensins (Schuhmann et al., 2003; Lee et al., 2004; 
Langen et al., 2006) synthesized via the Toll pathway in response to EPF 
infection (Vertyporokh and Wojda 2017). Lysozyme has both anti- 
bacterial and anti-fungal activity (Jolles and Jolles, 1984; Wojda 
et al., 2009; Sowa-Jasiłek et al., 2016), while IMPI is a G. mellonella- 
specific inhibitor of EPF metalloproteinases that hydrolyses insect pro-
teins in the cuticle and haemolymph (Vilcinskas and Wedde, 2002; 
Altincicek et al., 2007; Wedde et al., 2007), and is itself a target for EPF 
proteinases synthesized as a fungal countermeasure to the G. mellonella 
immune response (Mukherjee and Vilcinskas, 2018). Expression of IMPI 
has been shown previously to be up-regulated within 48 h of fungal 
infection (Vertyporokh and Wojda, 2017). Expression of both IMPI and 
lysozyme in G. mellonella is reported to be upregulated by a range of 
stimuli including fungal and bacterial infection (Vertyporokh and 
Wojda, 2017), metamorphosis and wounding (Griesch et al., 2000; 
Altincicek and Vilcinskas 2006; Vilcinskas, 2019). The signalling 
pathway(s) leading to IMPI and lysozyme expression in G. mellonella have 
yet to be fully elucidated, although they are likely to be regulated by 
Toll, Imd or a related pathway as their transcription is controlled by c- 
Rel proteins Relish, DIF and Dorsal (Altincicek and Vilcinskas, 2006; 
Vilcinskas, 2019). 
We observed no upregulation of galiomycin in response to fungal 
infection in G. mellonella, which may have been due to the route of 
infection (injection rather than topical application) or because gene 
expression was measured using whole insects rather than specific tis-
sues, such as the fat body, which is a site of AMP synthesis (Vertyporokh 
and Wojda, 2017). We chose injection as the way to deliver cordycepin 
to G. mellonella as it mimics the normal route of exposure, since host 
tissues are exposed to it after fungal hyphae have grown into the insect 
haemocoel. Injection of EPF also allowed us to precisely control the dose 
of pathogen, and to ensure that cordycepin and EPF were applied at the 
same time and location. 
To date, studies on the effects of cordycepin have focused on the 
mammalian innate response rather than the insect immune system (for 
example see Chu and Edelman, 1972; Penman et al., 1970; Kim et al., 
2006; Jeong et al., 2010; Kondrashov et al., 2012; Ren et al., 2012; 
Ashraf et al., 2019). The close similarities between aspects of the 
mammalian innate immune system and insect immunity - such as the 
homology between TLR (mammal) and Toll (insect) immune signalling 
(Sheehan et al., 2018) - would explain why cordycepin is able to affect 
both mammalian and insect immune responses. Cordycepin treatment is 
reported to reduce inflammatory mRNAs in primary human airway 
smooth muscle cells and mouse macrophage cells treated with an 
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inflammatory stimulus (Kondrashov et al., 2012; Ashraf et al., 2019). 
The precise mechanism(s) of action of cordycepin on mammalian cells is 
not yet known, although there is evidence that it can prevent nuclear 
translocation of NFκB in mammalian microglia, embryonic kidney and 
macrophage cells (Jeong et al., 2010; Ren et al., 2012; Ashraf et al., 
2019), while it has also been shown to affect a subset of polyadenylated 
mRNAs in a variety of human cell types, (Penman et al., 1970; Chu and 
Edelman, 1972; Kondrashov et al., 2012). 
Secondary metabolites play an important role in the pathogenicity of 
EPF (de Bekker et al., 2013) and - in principle - the deployment of me-
tabolites for active suppression of the insect immune response would be 
beneficial for fungal fitness. The array of secondary metabolites pro-
duced by non-specialist EPF has been shown to vary between species, 
insect tissue type, and whether fungal growth is infectious or sapro-
trophic (i.e. in living or dead tissue) (de Bekker et al., 2013). It is 
possible that some of these compounds function as immunosuppressors, 
but may also have additional roles. For example, injection of destruxin A 
into D. melanogaster, mimicking infection by Metarhizium species, 
reduced expression of AMPs and made them susceptible to infection by 
normally non-pathogenic E. coli by inhibition of the IMD pathway (Pal 
et al., 2007). However destruxin A (as well as destruxins B and E) has 
also been found to have insecticidal activity against Spodoptera litura 
(Lepidoptera) and, in the same study, a crude destruxin preparation was 
found to have synergistic effects on the pathogenicity of Cordyceps jav-
anica (Hypocreales, Cordycipitaceae) (formerly Paecilomyces javanicus 
and Isaria javanica) to S. litura (Hu et al., 2007), which echoes our 
finding of a synergistic interaction between co-application of exogenous 
cordycepin together with C. militaris or B. bassiana. 
Few studies have been done on the mechanisms of pathogenesis by 
C. militaris, but there is evidence that passive avoidance of immune 
detection is less important for successful infection compared to gener-
alist EPF species (Kryukov et al., 2020). Our finding that cordycepin was 
able to suppress the expression of different antimicrobial effectors is 
likely to be of benefit to C. militaris as an immune interference strategy, 
as insect defence compounds are known to operate synergistically 
against pathogen infections (Kaur et al., 2015; Butt et al., 2016). 
Therefore, the ability to suppress the activity of a range of defence 
compounds at once might be a more efficient - and therefore selectively 
advantageous - strategy than targeting individual compounds with 
different suppressors. The production of cordycepin by C. militaris has 
been found to vary between 750 and 16500 µg g  1 depending on fungal 
strain, cultivation method and extraction method (Huang et al., 2003; Li 
et al., 2004; Yang and Li, 2008). Therefore, the amount of cordycepin 
used in our experiments probably represents a higher dose than that 
received by a G. mellonella larva (which weighed 200–300 mg) when 
infected with C. militaris on its own: the evidence for this is that injection 
of C. militaris into G. mellonella still resulted in an increase in expression 
of immune related genes, even though this fungus is known to synthesize 
cordycepin. This raises a question of why, if cordycepin is able to supress 
the immune response and increase the virulence of the fungus, is it not 
produced at higher levels in natural infections by C. militaris? It has been 
proposed that there is a trade-off between metabolite production and 
EPF growth, as highly active toxins could result in host mortality before 
the fungus has grown sufficient biomass to produce structures needed 
for spore production, and which would also leave the host cadaver 
vulnerable to fast growing, saprotrophic microbes (Boomsma et al., 
2014). In our study, cordycepin was lethal to G. mellonella larvae 
depending on the dose applied. Larvae killed by cordycepin injection 
exhibited the symptoms of a bacterial infection (Tanada and Kaya, 
1993) and we were able to recover opportunist bacterial pathogens from 
them including Bacillus sp., Enterobacter sp., Enterococcus sp. Pantoea sp. 
and Serratia sp. (Woolley, 2018). Similar symptoms were observed by 
Kim et al., (2002), who found that larvae of the diamondback moth 
Plutella xylostella (Lepidoptera: Plutellidae) fed leaf discs treated with 
cordycepin (25–500 mg l  1) became dark brown and then lysed after 
death. A methanolic extract of the C. militaris fruiting body has been 
found to exhibit antibacterial and antifungal properties (Reis et al., 
2013), which suggests that in vivo, C. militaris produces metabolites that 
may prevent opportunistic infections of the fruiting body by bacteria or 
fungi. 
Further work needs to be conducted to elucidate the mode of action 
of cordycepin during insect infection by C. militaris. In particular, it 
would be important to determine how cordycepin inhibits AMP 
expression, including effects on the activity of transcription factors in 
the Toll and Imd pathways (Kondrashov et al., 2012; Ren et al., 2012) 
and polyadenylation of immune genes (Kondrashov et al., 2012). It 
would also be worth investigating whether cordycepin has an effect on 
the cellular immune response, including the prophenol oxidase cascade 
and wounding response. Although our study suggests that cordycepin 
may play a role in the virulence of C. militaris, conclusive proof would be 
needed by construction of knock outs of the genes responsible for cor-
dycepin production (Xia et al., 2017). Improved knowledge of the EPF- 
host immune interaction may help us understand the selection pressures 
affecting fungal pathogenicity and host immune defences (Boomsma 
et al., 2014; Mukherjee and Vilcinskas, 2018), as well as practical ap-
plications such as the selection and development of EPF strains for 
biological pest control or the identification of secondary metabolites as 
novel pesticides, efficacy enhancing agents, or pharmaceuticals (Butt 
et al., 2016). 
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